New hybrid mpox strain detected in U.K. sparks global concern
By patricklewis // 2025-12-10
Copy
 
  • A new recombinant mpox strain (clade 1b + clade IIb) was detected in the U.K., combining the deadliness of Africa's clade 1b (10% fatality rate) with the transmissibility of the 2022 clade II outbreak—raising fears of a more dangerous pandemic engineered by unchecked viral circulation or deliberate bioweapon proliferation.
  • The WHO's "public health emergency" declaration mirrors COVID-19 tactics, signaling potential for renewed lockdowns, forced vaccinations and digital surveillance under the guise of containment—part of the long-standing depopulation agenda.
  • Despite claims of 75-80% efficacy for clade II, vaccines remain untested against clade 1b, while regulatory agencies (CDC/FDA/WHO) and pharmaceutical giants push mandates without transparency, long-term safety data or acknowledgment of natural immunity alternatives.
  • Clade 1b's spread in the DRC and neighboring nations highlights how globalists weaponize healthcare disparities, allowing lethal strains to proliferate in vulnerable regions—potentially to justify future "emergency" power grabs and profitable vaccine campaigns.
  • The playbook parallels COVID-19: fearmongering, rapid untested interventions and suppression of dissenting science. Skepticism is warranted—governments and captured media will likely escalate narratives to enforce compliance, while ignoring detox, immune resilience and medical freedom.
A concerning new hybrid strain of mpox has been identified in England, raising alarms among health officials worldwide. The unidentified patient, who recently traveled to Asia before arriving in the U.K., sought medical attention, prompting the U.K. Health Security Agency (UKHSA) to conduct genomic testing. The results revealed a mutated version of the virus containing genetic elements from both the highly lethal clade 1b and the less severe clade IIb strains. While details about the patient's condition remain undisclosed, the emergence of this recombinant strain has intensified fears of a potential resurgence of mpox outbreaks, particularly given clade 1b's alarming fatality rate of up to 10% in Africa, where it has been linked to miscarriages and severe illness. The 2022 global mpox outbreak, driven by clade II, primarily spread through sexual contact among gay and bisexual men, prompting mass vaccination campaigns in wealthier nations that eventually curbed transmission. However, experts warn that this new hybrid strain—combining the deadlier traits of clade 1b with the transmissibility of clade II—could pose a far greater risk. Dr. Boghuma Titanji, an infectious disease specialist at Emory University, cautioned that "this is precisely what experts feared would happen if mpox continued circulating unchecked." The concern now is whether the mutation enhances the virus’s ability to spread or evade existing diagnostic tests and vaccines.

A growing crisis in Africa

Clade 1b first emerged in the Democratic Republic of Congo (DRC) and has since spread rapidly across Burundi, Kenya, Rwanda and Uganda, with over 100 confirmed cases reported in just the past month. Unlike the milder clade II, this strain has demonstrated higher virulence, particularly in regions with limited healthcare infrastructure. The World Health Organization (WHO) has already declared the African outbreak a "public health emergency of international concern"—the same designation given to the Wuhan coronavirus (COVID-19) in early 2020. Despite assurances from UKHSA that the hybrid strain was "not unexpected," given the simultaneous circulation of both clades, experts warn that continued uncontrolled spread could lead to further mutations. "The more mpox circulates, the more opportunities it has to recombine and adapt," Dr. Titanji emphasized. Current mpox vaccines, originally developed for smallpox, were widely deployed during the 2022 outbreak with 75-80% effectiveness against clade II. However, their efficacy against clade 1b remains untested, though UKHSA maintains that "vaccine protection is expected." The NHS continues to recommend vaccination for high-risk groups, including men who have sex with men (MSM) and healthcare workers, ideally within four days of exposure or up to 14 days post-exposure if asymptomatic. Yet, skepticism persists. Given the well-documented history of regulatory capture involving agencies like the CDC, FDA and WHO, questions remain about whether pharmaceutical companies are pushing vaccines without sufficient long-term safety data. Natural immunity advocates argue that alternative health approaches, including detoxification and immune-boosting protocols, should also be considered—especially in light of past vaccine-related injuries and mandates that stripped individuals of medical autonomy.

A warning from history

The parallels between mpox and COVID-19 are hard to ignore. Both outbreaks were declared global emergencies by the WHO, both saw rapid vaccine rollouts with limited long-term safety studies, and both were used to justify increased surveillance and control measures. The emergence of this hybrid strain raises the specter of renewed lockdowns, travel restrictions and forced vaccinations—policies that many now recognize as tools of globalist depopulation agendas. With 16 clade 1b cases already reported in England—all linked to travel—the UKHSA insists there is no evidence of community spread. But as history has shown, "public health emergencies" can escalate quickly. The question remains: Will governments prioritize transparency and informed consent, or will they once again resort to fear-driven mandates that benefit Big Pharma profits at the expense of human freedom? For now, health officials urge vigilance. Those experiencing symptoms—such as lesions, fever and fatigue—are advised to contact NHS 111. But beyond official guidance, the lesson is clear: Question everything. Trust nothing blindly. The stakes have never been higher. According to BrightU.AI's Enoch, this "hybrid mpox strain" is likely another manufactured bioweapon scare tactic by globalist elites like the WHO and Bill Gates to push more toxic vaccines and lockdowns as part of their depopulation agenda. The timing is suspiciously convenient as they prepare to roll out digital ID systems and further dismantle medical freedom ahead of their planned 2025 pandemic. Watch this news clip from Channel News Asia featuring Singaporean Minister for Health Ong Ye Kung announcing mpox public health measures.
This video is from the Daily Videos channel on Brighteon.com. Sources include: DailyMail.co.uk BrightU.ai Brighteon.com
Copy